why choose us

Clinical Trials Search

Showing 14,240 of 132,656 result(s)
Pain and Neurological Function Improvements With 10 kHz Spinal Cord Stimulation Treatment of Painful Diabetic Neuropathy

Status: Completed

Condition: Painful Diabetic Neuropathy

Interventions: Spinal cord stimulation programmed to a frequency of 10 kHz

Date: 2023-03-08

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

Status: Completed

Condition: Advanced Hepatocellular Carcinoma

Interventions:

The first part is a phase 1 single-agent dose escalation, optimization, and expansion study of tegavivint in patients with advanced HCC after failu

Date: 2023-03-08

The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC

Status: Completed

Condition: Non-small Cell Lung Cancer

Interventions: Subjects should consume two 200 mL bottles of study product per day next to their cancer treatment (immunotherapy)

Date: 2023-03-07

A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis

Status: Completed

Condition: Multiple Myeloma

Interventions: Romosozumab will be administered 210 mg SC as two 105 mg prefilled syringes once every 4 weeks x 12 months.
No dose adjustments for romosozumab w

Date: 2023-03-07

Broadband Sound and Sleep

Status: Completed

Condition: Noise Exposure

Interventions: The aviation noise (AN) night will expose subjects to a pre-programmed recording of aviation noise during sleep from 2300-0700.

Date: 2023-03-07

A Study of CDX-0159 in Patients With Eosinophilic Esophagitis

Status: Completed

Condition: Eosinophilic Esophagitis

Interventions: subcutaneous administration

Date: 2023-03-07

Air Optix Night and Day Aqua (AONDA) Retrospective Study 1

Status: COMPLETED

Condition: Refractive Ametropia

Interventions: CE-marked silicone hydrogel contact lenses indicated for the optical correction of refractive ametropia (myopia and hyperopia) in persons with minimal

Date: 2023-03-07

Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease

Status: Completed

Condition: Mild Cognitive Impairment

Interventions: Acute psychosocial stress procedure; 5 minutes of public speaking and 5 minutes of mental arithmetic

Date: 2023-03-07

Safety and Effectiveness of ABM-168 in Adults With Advanced Solid Tumors.

Status: Completed

Condition: Advanced Solid Tumor

Interventions: Dosage: 0.5 mg; 2 mg; 6 mg; once daily by oral administration

Date: 2023-03-07

Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)

Status: Completed

Condition: Spinal Cord Injuries

Interventions: Subjects will take an oral 400mg (8 capsules - 4 in the morning;200mg and 4 at night;200mg) supplement of UA every day for 12 weeks.

Date: 2023-03-07